|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/48 | |
| A61P 7/04 |
| (11) | Patento numeris | 2101821 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07865679.0 |
| Europos patento paraiškos padavimo data | 2007-12-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-09-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-08-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/087553 |
| Data | 2007-12-14 |
| (87) | Numeris | WO 2008/074032 |
| Data | 2008-06-19 |
| (30) | Numeris | Data | Šalis |
| 875217 P | 2006-12-15 | US |
| (72) |
TURECEK, Peter, AT
SIEKMANN, Juergen, AT
SCHEIFLINGER, Friedrich, AT
CANAVAGGIO, Michel, AT
|
| (73) |
Baxter International Inc.,
One Baxter Parkway, Deerfield, IL 60015,
US
Baxter Healthcare SA, Thurgauerstrasse 130, 8152 Glattpark (Opfikon), CH |
| (54) | FACTOR VIIA- (POLY) SIALIC ACID CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE |
| FACTOR VIIA- (POLY) SIALIC ACID CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE |